Arrowstreet Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Arrowstreet Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,294	Closed	-$328K	–	1960
2026 Q1	$328K	Sell	15,294 -239,728	-94%	-$3.38M	﹤0.01%	1724
2025 Q4	$2.38M	Buy	+255,022	New	+$2.13M	﹤0.01%	1357

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arrowstreet Capital's DAWN Position: Q2 2026 in Review

Arrowstreet Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 15,294 shares — an estimated $328K sold.

Arrowstreet Capital first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $2.38M in Q4 2025. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Arrowstreet Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Arrowstreet Capital sold 15,294 Day One Biopharmaceuticals shares in Q2 2026, an estimated $328K.
Arrowstreet Capital first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
Arrowstreet Capital's Day One Biopharmaceuticals position peaked at $2.38M in Q4 2025.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.